AAAAAA

   
Results: 1-25 | 26-48 |
Results: 26-48/48
Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy - A report of five cases
Authors: Kouroussis, C Samonis, G Androulakis, N Souglakos, J Voloudaki, A Dimopoulos, MA Kotsakis, T Kakolyris, S Kalbakis, K Georgoulias, V
Citation: C. Kouroussis et al., Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy - A report of five cases, AM J CL ONC, 23(3), 2000, pp. 309-313
Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin'slymphomas
Authors: Kanavaros, P Stefanaki, K Vlachonikolis, J Eliopoulos, C Kakolyris, S Rontogianni, D Gorgoulis, V Georgoulias, V
Citation: P. Kanavaros et al., Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin'slymphomas, HIST HISTOP, 15(2), 2000, pp. 445-453
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy
Authors: Kakolyris, S Souglakos, J Agelaki, S Kourousis, C Mavroudis, D Sarra, E Malliotakis, P Georgoulias, V
Citation: S. Kakolyris et al., A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy, LUNG CANC, 30(3), 2000, pp. 193-198
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report
Authors: Mavroudis, D Kourousis, C Kakolyris, S Agelaki, S Kalbakis, K Androulakis, N Souglakos, J Vardakis, N Samonis, G Georgoulias, V
Citation: D. Mavroudis et al., Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report, SEMIN ONCOL, 27(1), 2000, pp. 25-30
Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer
Authors: Koukourakis, MI Giatromanolaki, A Thorpe, PE Brekken, RA Sivridis, E Kakolyris, S Georgoulias, V Gatter, KC Harris, AL
Citation: Mi. Koukourakis et al., Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer, CANCER RES, 60(11), 2000, pp. 3088-3095
Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39
Authors: Kakolyris, S Fox, SB Koukourakis, M Giatromanolaki, A Brown, N Leek, RD Taylor, M Leigh, IM Gatter, KC Harris, AL
Citation: S. Kakolyris et al., Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39, BR J CANC, 82(4), 2000, pp. 844-851
Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectaladenocarcinomas
Authors: Kanavaros, P Stefanaki, K Valassiadou, K Vlachonikolis, J Mavromanolakis, M Vlychou, M Kakolyris, S Gorgoulis, V Tzardi, M Georgoulias, V
Citation: P. Kanavaros et al., Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectaladenocarcinomas, MED ONCOL, 16(1), 1999, pp. 23-30
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation study
Authors: Kouroussis, C Xydakis, E Potamianou, A Giannakakis, T Kakolyris, S Agelaki, S Sara, E Malamos, N Alexopoulos, A Mavroudis, D Samonis, G Papadouris, S Georgoulias, V Panagos, G
Citation: C. Kouroussis et al., Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation study, ANN ONCOL, 10(5), 1999, pp. 547-552
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial
Authors: Mavroudis, D Malamos, N Alexopoulos, A Kourousis, C Agelaki, S Sarra, E Potamianou, A Kosmas, C Rigatos, G Giannakakis, T Kalbakis, K Apostolaki, F Vlachonicolis, J Kakolyris, S Samonis, G Georgoulias, V
Citation: D. Mavroudis et al., Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial, ANN ONCOL, 10(2), 1999, pp. 211-215
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: A multicenter phase II study
Authors: Androulakis, N Kourousis, C Dimopoulos, MA Samelis, G Kakolyris, S Tsavaris, N Genatas, K Aravantinos, G Papadimitriou, C Karabekios, S Stathopoulos, GP Georgoulias, V
Citation: N. Androulakis et al., Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: A multicenter phase II study, J CL ONCOL, 17(6), 1999, pp. 1779-1785
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer
Authors: Kouroussis, C Androulakis, N Kakolyris, S Souglakos, J Kotsakis, T Mavroudis, D Katsogridakis, K Vardakis, N Hatzidaki, D Samonis, G Vlachonikolis, J Georgoulias, V
Citation: C. Kouroussis et al., Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer, J CL ONCOL, 17(3), 1999, pp. 862-869
Front-line treatment of advanced non-small-cell lung cancer with docetaxeland gemcitabine: A multicenter phase II trial
Authors: Georgoulias, V Kouroussis, C Androulakis, N Kakolyris, S Dimopoulos, MA Papadakis, E Bouros, D Apostolopoulou, F Papadimitriou, C Agelidou, A Hatzakis, K Kalbakis, K Kotsakis, A Vardakis, N Vlachonicolis, J
Citation: V. Georgoulias et al., Front-line treatment of advanced non-small-cell lung cancer with docetaxeland gemcitabine: A multicenter phase II trial, J CL ONCOL, 17(3), 1999, pp. 914-920
Concurrent twice-a-week docetaxel and radiotherapy: A dose escalation trial with immunological toxicity evaluation
Authors: Koukourakis, MI Giatromanolaki, A Schiza, S Kakolyris, S Georgoulias, V
Citation: Mi. Koukourakis et al., Concurrent twice-a-week docetaxel and radiotherapy: A dose escalation trial with immunological toxicity evaluation, INT J RAD O, 43(1), 1999, pp. 107-114
First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin
Authors: Kakolyris, S Kourousis, C Koukourakis, M Androulakis, N Vamvakas, L Agelaki, S Hatzidaki, D Samonis, G Tsiftsis, D Georgoulias, V
Citation: S. Kakolyris et al., First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin, AM J CL ONC, 22(6), 1999, pp. 568-572
First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrolacetate in advanced breast cancer
Authors: Kakolyris, S Samonis, G Koukourakis, M Vlachonicolis, J Kalbakis, K Agelaki, S Chalkiadakis, G Sanidas, E Tsiftsis, D Georgoulias, V
Citation: S. Kakolyris et al., First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrolacetate in advanced breast cancer, AM J CL ONC, 22(3), 1999, pp. 273-277
Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4(+) cell proliferation
Authors: Sara, E Kotsakis, A Souklakos, J Kourousis, C Kakolyris, S Mavromanolakis, E Vlachonicolis, J Georgoulias, V
Citation: E. Sara et al., Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4(+) cell proliferation, ANTICANC R, 19(1A), 1999, pp. 471-476
Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC)
Authors: Kakolyris, S Giatromanolaki, A Koukourakis, M Kaklamanis, L Kanavaros, P Hickson, ID Barzilay, G Georgoulias, V Gatter, KC Harris, AL
Citation: S. Kakolyris et al., Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC), J PATHOLOGY, 189(3), 1999, pp. 351-357
Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: Correlation with p53 and angiogenic factor expression
Authors: Kakolyris, S Giatromanolaki, A Koukourakis, M Leigh, IM Georgoulias, V Kanavaros, P Sivridis, E Gatter, KC Harris, AL
Citation: S. Kakolyris et al., Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: Correlation with p53 and angiogenic factor expression, CANCER RES, 59(21), 1999, pp. 5602-5607
Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma
Authors: Makris, A Powles, TJ Kakolyris, S Dowsett, M Ashley, SE Harris, AL
Citation: A. Makris et al., Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma, CANCER, 85(9), 1999, pp. 1996-2000
Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer
Authors: Giatromanolaki, A Koukourakis, MI Kakolyris, S Turley, H O'Byme, K Scott, PAE Pezzella, F Georgoulias, V Harris, AL Gatter, KC
Citation: A. Giatromanolaki et al., Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer, CLIN CANC R, 4(12), 1998, pp. 3017-3024
Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial
Authors: Alexopoulos, K Kouroussis, C Androulakis, N Papadakis, E Vaslamatzis, M Kakolyris, S Samelis, G Patila, E Vossos, A Samantas, E Georgoulias, V
Citation: K. Alexopoulos et al., Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial, CANC CHEMOT, 43(3), 1998, pp. 257-262
Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein: a basis for its role in human disease
Authors: Kakolyris, S Kaklamanis, L Giatromanolaki, A Koukourakis, M Hickson, ID Barzilay, G Turley, H Leek, RD Kanavaros, P Georgoulias, V Gatter, KC Harris, AL
Citation: S. Kakolyris et al., Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein: a basis for its role in human disease, HISTOPATHOL, 33(6), 1998, pp. 561-569
Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation
Authors: Giatromanolaki, A Fountzilas, G Koukourakis, MI Arapandoni, P Theologi, V Kakolyris, S Georgoulias, V Harris, AL Gatter, KC
Citation: A. Giatromanolaki et al., Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation, CLIN EXP M, 16(7), 1998, pp. 665-672
Risultati: 1-25 | 26-48 |